Inflammatory conditions affect more than 7 million Canadians
A $2.5 million project called ‘PRECISION’ is underway. It will study more than a million Canadians with inflammatory diseases of the skin, joint or bowel
Read MoreApril 30, 2019
Patients are at the forefront of much of our work. Our investigators strive to make a measurable difference in improving outcomes and quality of life. They study new treatments and medications, and through rigorous research, they develop innovative methods and approaches to address patient priorities.
A $2.5 million project called ‘PRECISION’ is underway. It will study more than a million Canadians with inflammatory diseases of the skin, joint or bowel
Read More
The GenCOUNSEL project aims to figure out the best ways to provide equitable access to genetic counselling for genome-wide sequencing in Canada.
Read More
PORTIA is the latest study in a long-term program of research that is developing evidence-based overdose prevention strategies and helping address the opioid crisis
Read More
CHÉOS is supportying a number of studies looking at how changes to diet and exercise habits can improve the health of people with or at risk for type 2 diabetes
Read More
Drs. Rick Sawatzky and Jose Valderas were awarded a 2019 UBC Partnership Development Fund Grant for a collaborative initiative between CHÉOS and the University of Exeter, UK.
Read More
For National Health Ethics Week, read about our newest Scientist, Dr. Anita Ho, and the unique approach she is taking to promoting ethical decision-making
Read More